945 related articles for article (PubMed ID: 32746878)
21. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
22. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
23. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27
Zeng X; Zhong M; Yang Y; Wang Z; Zhu Y
J Cell Mol Med; 2021 Apr; 25(8):4136-4147. PubMed ID: 33630417
[TBL] [Abstract][Full Text] [Related]
25. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
26. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
27. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L
Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092
[TBL] [Abstract][Full Text] [Related]
28. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract][Full Text] [Related]
29. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
[TBL] [Abstract][Full Text] [Related]
30. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC.
Chen C; Zhang M; Zhang Y
Cell Transplant; 2020; 29():963689720961070. PubMed ID: 32951448
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
Liu Y; Zhai R; Hu S; Liu J
Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
33. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
Jin J; Yao Z; Qin H; Wang K; Xin X
Biotechnol Lett; 2021 Jun; 43(6):1229-1240. PubMed ID: 33534015
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
Jiang Y; Wang K; Lu X; Wang Y; Chen J
Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
[TBL] [Abstract][Full Text] [Related]
36. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
37. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
38. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.
Xu YJ; Zhao JM; Gao C; Ni XF; Wang W; Hu WW; Wu CP
Cell Signal; 2021 Oct; 86():110095. PubMed ID: 34320370
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
[TBL] [Abstract][Full Text] [Related]
40. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
